Report Finds Parent Training Effective for Treating Young Children with ADHD
Formal training in parenting strategies is a low-risk, effective method for improving behavior in preschool-age children at risk for developing attention deficit hyperactivity disorder (ADHD), while there is less evidence supporting the use of medications for children younger than 6 years old, according to a new AHRQ report. The report found that formal parenting interventions—known as parent behavior training or PBT—are supported by strong evidence for effectiveness for children younger than the age of 6, with no reports of complications or harms. However, one large barrier to the success of PBT occurs when parents drop out of therapy programs, the report found. For children older than age 6, the report found that methylphenidate (sold under the brand name Ritalin) and another drug used to treat ADHD symptoms, atomoxetine (sold as Strattera), are generally safe and effective for improving behavior, but their effects beyond 12 to 24 months have not been well studied. Little information is available about the long-term effects of other medications used to treat ADHD symptoms. The report, “Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment,” was prepared for AHRQ’s Effective Health Care Program by the McMaster Evidence-based Practice Center in Hamilton, Ontario. Select to access the report and select to read our press release.
Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long- Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment - Research Review - Final AHRQ Effective Health Care ProgramFormal training in parenting strategies is a low-risk, effective method for improving behavior in preschool-age children at risk for developing attention deficit hyperactivity disorder (ADHD), while there is less evidence supporting the use of medications for children younger than 6 years old, according to a new AHRQ report. The report found that formal parenting interventions—known as parent behavior training or PBT—are supported by strong evidence for effectiveness for children younger than the age of 6, with no reports of complications or harms. However, one large barrier to the success of PBT occurs when parents drop out of therapy programs, the report found. For children older than age 6, the report found that methylphenidate (sold under the brand name Ritalin) and another drug used to treat ADHD symptoms, atomoxetine (sold as Strattera), are generally safe and effective for improving behavior, but their effects beyond 12 to 24 months have not been well studied. Little information is available about the long-term effects of other medications used to treat ADHD symptoms. The report, “Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment,” was prepared for AHRQ’s Effective Health Care Program by the McMaster Evidence-based Practice Center in Hamilton, Ontario. Select to access the report and select to read our press release.
Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long- Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment
Formats
- View PDF 2.6 MB full-text:
- http://www.effectivehealthcare.ahrq.gov/ehc/products/191/818/CER44-ADHD_20111021.pdf
- Help with Viewers, Players, and Plug-ins
This final research review is available in PDF (2.6 MB) form only. Persons using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us.
.png)
No hay comentarios:
Publicar un comentario